meddevicedb.com FDA Device Reference

LigaPASS™ 2.0 Ligament Augmentation System

K213659 Class II Traditional
Decision Date
2022-05-24
Sponsor / Applicant
Medicrea International SA

Technical Specification

510(k) Submission ID K213659
Product Code OWI
Medical Specialty / Panel Orthopedic
Regulation Citation 21 CFR 888.3010
Decision Date 2022-05-24
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

LigaPASS™ 2.0 Ligament Augmentation System received FDA 510(k) clearance under submission number K213659, sponsored by Medicrea International SA. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2022-05-24.

Classification & Regulation

This clearance is catalogued under FDA product code OWI and 21 CFR 888.3010, within the Orthopedic review panel as a Class II device.